I can share an example where gene expression analysis was used to validate results from another experimental technique. In a study analyzing cancer recurrence risk, we initially relied on Next-Generation Sequencing (NGS) to detect genetic mutations associated with tumor progression. While NGS provided a comprehensive mutational profile, we needed additional confirmation on whether these mutations led to significant changes at the transcriptional level. To validate the findings, we performed qPCR-based gene expression analysis on key oncogenes and tumor suppressor genes. Interestingly, while NGS detected mutations in certain genes, the expression analysis revealed that not all mutations led to significant transcriptional changes. This insight helped refine our interpretation - distinguishing between silent mutations and those actively influencing tumor behavior. By integrating gene expression analysis with sequencing data, we achieved a more robust and clinically relevant understanding of the patient's cancer profile. This approach enhanced treatment personalization, ensuring targeted therapies were chosen based on both genomic alterations and their downstream effects.